).
7. Astier, B., et al., In vivo comparison of two 5-HT1A
receptors agonists alnespirone (S-20499) and
buspirone on locus coeruleus neuronal activity.
Eur. J. Pharmacol., 459(1), 17-26 (2003).
generated after removal of the 26 amino acid residue
signal peptide, has a predicted molecular mass of
approximately 18 kDa. The gene for FL has been
mapped to chromosome 7 in the mouse.
The Flt-3 (
Gene, 88,
285-288 (1990).
6. Wendt, S. et al., Curr. Genet., 17, 21-24 (1990).
7. Cullen, D. et al., Gene, 57, 21-26 (1987).
8. Van de Rhee, M.D. et al., Mol. Gen. Genet., 250,
252-258 (1996).
embryonic stem
cell renewal media.5
Recombinant human Vitronectin is a protein consisting
of 459 amino acids. It exists in two forms: a single
chain and a clipped form consisting of two chains
.
3. Shi, Y. Mechanisms of caspase activation and
inhibition during apoptosis. Mol. Cell, 9, 459-470
(2002).
4. Cory, S., Adams, J.M., The Bcl2 family: regulators
of the cellular life-or-death
inhibin. J. Reprod. Fertil., 26, 47 (1979).
6. Woodruff, T.K., Regulation of cellular and system
function by activin. Biochem. Pharmacol., 55, 953-
963 (1998).
7. Ying, S.Y., et al., Activins and
et al, Isolation of two novel genes,
down-regulated in gastric cancer. Jpn. J. Cancer
Res., 91, 459-63 (2000).
4. Lee, H.J. et al, Characterization of a human
digestive tract-specific calpain
et al, Isolation of two novel genes,
down-regulated in gastric cancer. Jpn. J. Cancer
Res., 91, 459-63 (2000).
4. Lee, H.J. et al, Characterization of a human
digestive tract-specific calpain
et al, Isolation of two novel genes,
down-regulated in gastric cancer. Jpn. J. Cancer
Res., 91, 459-63 (2000).
4. Lee, H.J. et al, Characterization of a human
digestive tract-specific calpain
et al, Isolation of two novel genes,
down-regulated in gastric cancer. Jpn. J. Cancer
Res., 91, 459-63 (2000).
4. Lee, H.J. et al, Characterization of a human
digestive tract-specific calpain
et al. (1978) Eur. J. Biochem. 87, 21-27.
2 Gonzales, A. et al. (1978) Biochem. Biophys. Acta 521, 459-469.
3 Singh, A. et al. (1979) Nature 277, 146-148.
4 Malpartida, F. et al. (1983) Biochem. Biophys
al., J. Pharmacol. Exp. Ther., 275, 368-373 (1995).
51. Yokotani, K., et al., Eur. J. Pharmacol., 459, 187-193 (2003).
52. Kiriyama, M., et al., Br. J. Pharmacol., 122, 217-224 (1997).
53. Bygdeman, M.